Form 8-K - Current report:
SEC Accession No. 0001104659-25-105199
Filing Date
2025-11-03
Accepted
2025-11-03 06:46:28
Documents
13
Period of Report
2025-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2530004d1_8k.htm   iXBRL 8-K 25235
2 EXHIBIT 99.1 tm2530004d1_ex99-1.htm EX-99.1 62056
  Complete submission text file 0001104659-25-105199.txt   264285

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lqda-20251103.xsd EX-101.SCH 3014
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lqda-20251103_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lqda-20251103_pre.xml EX-101.PRE 22358
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2530004d1_8k_htm.xml XML 3652
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39724 | Film No.: 251442046
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)